Cannabis Regulatory Commission

Commission Leadership

The New Jersey Cannabis Regulatory Commission seeks to establish and grow a responsible, regulated medicinal and recreational cannabis industry. By applying the values of safety and equity, the Commission will center its work around creating and protecting access for patients, the production of safe products, and promoting diversity and inclusion in the industry to develop a national model for sensible, fair oversight.

The Commission is committed to transparency and the public good. The agency operates under a Code of Ethics beyond the New Jersey Conflicts of Interest Law, the New Jersey Uniform Ethics Code, and the medicinal and adult-use cannabis statutes.

Chairs

Dianna Houenou, Photo of

Dianna Houenou

Chair

 Sam Delgado, photo of

Sam Delgado

Vice Chair

Commissioners

 Maria Del Cid-Kosso, photo of

Maria Del Cid-Kosso

Commissioner

Photo of, Amelia Mapp

Amelia Mapp

Commissioner

 Krista Nash, photo of

Krista G. Nash

Commissioner

Administrative Leadership

 Christopher Riggs, photo of

Christopher Riggs

Acting Executive Director

David Tuason, photo of

Dave Tuason

Chief Counsel

Wesley McWhite III, photo of

Wesley McWhite III

Director, Office of Diversity and Inclusion

Paul Urbish, photo of

Paul Urbish

Director, Compliance and Investigations

Megan Tagliaferri, photo of

Megan Tagliaferri

Director, Licensing

Toni-Anne Blake, photo of

Toni-Anne Blake

Director, Communications

Committee Assignments

Commissioner Assigned: Chair Houenou, Vice Chair Delgado

Committee Scope: Responsible for the development and approval of the Commission’s budget, and review and monitoring of (1) the Commission’s financial statements and the adequacy of its financial controls, (2) the results of any audit, and (3) compliance with all legal, regulatory, and ethical requirements. The Audit Committee will also be responsible for, in coordination with the Executive Director, coordination, review, drafting, and approval of regular annual, biennial, and other statutorily required reports before submission for consideration by the Commission. The Audit Committee is also responsible for securing a study to be conducted by a public research university at the 3-year anniversary of the inaugural Commission public meeting to review the Commission’s organization, activities, and effectiveness.

Commissioner Assigned: Vice Chair Delgado, Commissioner Mapp 

Committee Scope: Responsible for developing, reviewing and approving public awareness campaigns. The Public Engagement and Education Committee will also organize public hearings required by statute to solicit input on the appropriation of social equity excise fee revenues and will prepare a recommendation report on the findings to be adopted the Commission. It will also be the responsibility of the Public Engagement and Education Committee to review, assess, and make recommendations on the need for new research or investigation of the influence of cannabis on consumers driving ability, and methods to determine intoxication in consumers of cannabis.

Commissioner Assigned: Commissioner Mapp, Commissioner Nash 

Committee Scope: Responsible for monitoring complaints from patients and consumers to identify trends or patterns in product safety concerns. The Product Safety, Packaging, and Labeling Committee will also be charged with reviewing packaging and labeling issues for medicinal and personal-use cannabis, and for periodically reviewing Commission regulations concerning product safety, packaging, and labeling and soliciting related recommendations from stakeholders.

Commissioner Assigned: Commissioner Nash, Commissioner Del Cid-Kosso 

Committee Scope: Evaluate the regulations promulgated by the Commission for permitting and licensing of alternative treatment centers and cannabis businesses to ensure efficient licensing and permitting process for applicants. The Permitting/Licensing Committee will also review the numbers of licenses issued for each type of cannabis business to ensure the Commission is issuing an adequate number of licenses and permits to keep up with market demand.

Commissioner Assigned: Commissioner Nash, Commissioner Del Cid-Kosso

Committee Scope: Responsible for making recommendations to the full Board of Commissioners on appropriations of monies deposited in the Underage Deterrence and Prevention Account that will fund private for-profit and non-profit organizations, and county and municipal programs and services that are designed to improve and support youthful community activities to divert and prevent persons under 18 years of age from activities associated with the consumption of cannabis items.

Commissioner Assigned: Chair Houenou, Commissioner Del Cid-Kosso

Committee Scope: Work in collaboration with regulated businesses, patients, and health care practitioners to develop recommendations to the full Board for reducing patients’ costs for medical cannabis and ensuring equitable access to care. By December 1, 2025, the committee shall submit a report to the Board on the Committee’s findings, including any recommended Agency actions.

Commissioner Assigned: Chair Houenou, Commissioner Mapp

Other Agencies: Governor's Office, NJ Business Action Center

Committee Scope: Identify existing public or private business development support services to offer applicants and license holders (assistance with forming new a business, business plan development, etc.). Establish systems to coordinate information sharing.

Commissioner Assigned: Vice Chair Delgado

Other Agencies: Governor's Office, NJ Economic Development Authority

Committee Scope: Identify any available federal or State agencies that can provide funding programs for cannabis businesses. Define parameters for the program (grants versus loans, award amounts, eligibility, etc.). Identify the proper entity(ies) to administer/oversee the program. Establish systems to coordinate information sharing.